Fig. 1.
Expression of Ly49A transgene in the presence of MHC class I H-2Dd prevents lymphocyte expansion in CTLA-4–deficient mice.
Single-cell suspensions of lymph node cells were prepared, counted, and analyzed for the expression of cell surface markers using antibodies specific for CD4, CD8, and TCRαβ. Absolute number of CD4+ in Ly49ATg+H-2b/H-2d, CTLA-4 wild-type and deficient animals. Each dot represents a single animal. Ly49ATg+H-2Db: CTLA-4+/+,+/−, n = 9; CTLA-4−/−, n = 9; Ly49ATg+H-2Dd CTLA-4+/+,+/−, n = 31; CTLA-4−/−, n = 18. These animals were analyzed at 3 to 5 weeks of age, because the CTLA-4−/− mice that develop the lymphoproliferative disease die by 4 weeks of age. The difference in the absolute CD4+ T-cell number in the CTLA-4−/− mice expressing Ly49A transgene in the presence versus absence of the ligand H-2Dd was statistically significant (P < .001), whereas there was no statistically significant difference in the number of CD4+T cells between the Ly49ATg+ H-2Dd+CTLA-4−/− and the littermate control mice.